Meeting
2013 ASCO Annual Meeting
Pain sensitivity and aromatase inhibitor (AI)-associated arthralgias (AIAA).
Authors
Norah Lynn Henry
University of Michigan Medical Center, Ann Arbor, MI
Norah Lynn Henry , Steven Harte , Anna S.C. Conlon , Kent A. Griffith , Gabriela Ramirez , Jill Hayden , Jeffrey B. Smerage , Anne F. Schott , Daniel F. Hayes , David A. Williams , Daniel A Clauw
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Patient and Survivor Care
Track
Patient and Survivor Care
Sub Track
Palliative Care and Symptom Management
Citation
J Clin Oncol 31, 2013 (suppl; abstr 9615)
DOI
10.1200/jco.2013.31.15_suppl.9615
Abstract #
9615
Poster Bd #
37C
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The CROWN study (CaRdiac Outcomes With Near complete estrogen deprivation): A multicenter, prospective cohort study of cardiovascular outcomes in premenopausal women with hormone receptor positive breast cancer treated with ovarian suppression and an aromatase inhibitor.
First Author: Emily H. Douglas
Poster
2022 ASCO Annual Meeting
Socioeconomic disparities in supportive therapy use and tolerance of aromatase inhibitors in patients with early-stage, hormone-positive breast cancer.
First Author: Melanie Wain Kier
Poster
2022 ASCO Annual Meeting
Estradiol (E2) levels in premenopausal women with hormone receptor-positive (HR+) breast cancer (BC) on ovarian function suppression (OFS) with gonadotropin-releasing hormone agonists (GnRHa).
First Author: Megan Elizabeth Tesch
Poster
2018 ASCO Annual Meeting
Association of a low-expression SLCO1B1 polymorphism with estrogen concentrations before and during aromatase inhibitor treatment for breast cancer.
First Author: Jacqueline M Dempsey